ADRENERGIC BETA-ANTAGONISTS;
EVIDENCE-BASED MEDICINE;
GUIDELINE ADHERENCE;
HEART FAILURE, CONGESTIVE;
HOSPITALS;
HUMANS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PRACTICE GUIDELINES;
QUALITY OF HEALTH CARE;
UNITED STATES;
Heart Failure: Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction. Clinical Practice Guidelines
Rockville, MD: US Dept of Health and Human Services; June AHCPR Publication. 94-0612
Konstam M, Dracup K, Baker D, et al. Heart Failure: Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction. Clinical Practice Guidelines. Rockville, MD: US Dept of Health and Human Services; June 1994. AHCPR Publication. 94-0612.
Management of heart failure. The role of revascularization and treatment of patients with moderate left ventricular systolic dysfunction
Baker DW, Jones R, Hodges J, et al. Management of heart failure. The role of revascularization and treatment of patients with moderate left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534.
Management of heart failure. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction
Baker DW, Wright RE. Management of heart failure. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA. 1994;272:1614-1618.
Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on Evaluation and Management of Heart Failure)
Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. 1995;92:2764-2784
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacologic approaches
Heart Failure Society of America
Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction -pharmacologic approaches. J Cardiac Failure. 1999;5:357-382.